|
|||||
|
|
| 人转化生长因子β1基因重组腺病毒的构建与鉴定 | |
| 引用本文： | 曾昭勋,尹承慧,邱俊钦,陈宗雄. 人转化生长因子β1基因重组腺病毒的构建与鉴定[J]. 中国组织工程研究, 2012, 16(41): 7728-7732. DOI: 10.3969/j.issn.2095-4344.2012.41.026 |
| 作者姓名： | 曾昭勋 尹承慧 邱俊钦 陈宗雄 |
| 作者单位： | 解放军南京军区福州总医院骨科研究所,福建省福州市 350025 |
| 摘 要： | 背景：转化生长因子β1能促进多种细胞的生长增殖,是调控骨髓间充质干细胞向成骨方向定向分化的主要生长因子。目的：利用AdMax系统构建人转化生长因子β1(hTGF-β1)基因的重组腺病毒表达载体。方法：采用PCR方法克隆人转化生长因子β1基因cDNA后,插入线性化表达载体pAV-MCMV-EGFP-3FLAG中,转化E.coli DH5α感受态细胞,构建pAV-MCMV-hTGF-β1重组质粒。结果与结论：含目的基因的重组腺病毒质粒共转染293细胞进行病毒包装、扩增后, 经PCR、Western Blot检测得到转化生长因子β1重组腺病毒,其滴度约为1.25×1010 pfu/mL。表明利用AdMax系统成功可构建人转化生长因子β1腺病毒载体,并可满足进一步的转化生长因子β1成骨作用的研究。 |
| 关 键 词： | 转化生长因子β1 腺病毒载体 基因 转染 AdMax系统 |
| 收稿时间： | 2012-01-05 |
Construction and identification of recombinant adenovirus vectors encoding human transforming growth factor-beta 1 gene |
|
| Zeng Zhao-xun,Yin Cheng-hui,Qiu Jun-qin,Chen Zong-xiong. Construction and identification of recombinant adenovirus vectors encoding human transforming growth factor-beta 1 gene[J]. Chinese Journal of Tissue Engineering Research, 2012, 16(41): 7728-7732. DOI: 10.3969/j.issn.2095-4344.2012.41.026 | |
| Authors: | Zeng Zhao-xun Yin Cheng-hui Qiu Jun-qin Chen Zong-xiong |
| Affiliation: | Institute of Orthopedics, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, Fujian Province, China |
| Abstract: | BACKGROUND:Transforming growth factor-beta1 (TGF-β1) can promote the growth and proliferation of many cells and is one of main growth factors that regulate osteoblast differentiation of bone marrow mesenchymal stem cells.OBJECTIVE:To construct a recombinant adenoviral vector carrying the human TGF-β1 gene using the AdMax system which may be applicable in gene therapy of bone defect.METHODS:The hTGF-β1 gene sequence was amplified by PCR from cDNA template and then was inserted into shuttle plasmid pAV-MCMV-EGFP-3FLAG. The recombinant shuttle plasmid was constructed and transformed into E.coli DH5α.The recombinant pAV-MCMV-hTGF-β1 was obtained.RESULTS AND CONCLUSION:The recombinant pAV-MCMV-hTGF-β1 was packaged and amplified in 293 cells. Then the recombinant TGF-β1 adenovirus was constructed successfully. After measuring the titre of virus (1.25×1010 pfu/mL), the target gene was evaluated by PCR and Western Blot. These findings suggest that construction of hTGF-β1 adenoviral vector was successfully achieved using the AdMax system and may be available in the future study of TGF-β1 gene therapy. |
| Keywords: | |
| 点击此处可从《中国组织工程研究》浏览原始摘要信息 | |
| 点击此处可从《中国组织工程研究》下载全文 | |